Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Diarrhea, Joint swelling, Increased CD4+ T cell proportion, and Failure to thrive in infancy and others; and common findings: Lymphadenopathy, Abdominal pain, Myalgia, and Vasculitis and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 3 | Diarrhea, Abdominal pain, Chronic diarrhea |
OTULIN encodes OTU deubiquitinase with linear linkage specificity (352 aa). Deubiquitinase that specifically removes linear ('Met-1'-linked) polyubiquitin chains to substrates and acts as a regulator of angiogenesis and innate immune response. Highest expression in Cells EBV-transformed lymphocytes (21.5 TPM) and Skin Not Sun Exposed Suprapubic (20.0 TPM).
Autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive is associated with mutations in the OTULIN gene on chromosome 5.
The OTULIN protein participates in Synthesis of active ubiquitin: roles of E1 and E2 enzymes pathway.
OTULIN is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for OTULIN is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 14 always present features, 5 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive.
8 publications have been identified in PubMed for autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive. Research spans Review / Meta-Analysis (38%), Basic Science / Preclinical (38%), and Case Report / Case Series (25%).
Koga T (2026). [PMID: 41620931](https://pubmed.ncbi.nlm.nih.gov/41620931/). *Expert review of clinical immunology*. [Review / Meta-Analysis]
Fan J (2025). [PMID: 40372975](https://pubmed.ncbi.nlm.nih.gov/40372975/). *Molecular reproduction and development*. [Basic Science / Preclinical]
van der Linden TJ (2025). [PMID: 41293556](https://pubmed.ncbi.nlm.nih.gov/41293556/). *Journal of human immunity*. [Case Report / Case Series]
Quoc QL (2024). [PMID: 38599290](https://pubmed.ncbi.nlm.nih.gov/38599290/). *The Journal of allergy and clinical immunology*. [Basic Science / Preclinical]
Spaan AN (2024). [PMID: 38652463](https://pubmed.ncbi.nlm.nih.gov/38652463/). *The Journal of experimental medicine*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 9:34 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive
Blood and immune system |
3 |
Increased total neutrophil count, Elevated white blood cell count (increased total leukocyte count), Vasculitis |
Bones and joints | 2 | Joint swelling, Arthralgia |
Lab test results | 2 | Increased circulating IgA concentration, Elevated CRP (inflammation marker) (elevated circulating c-reactive protein concentration) |
Growth and development | 1 | Failure to thrive in infancy |
Metabolism | 1 | Recurrent fever |
Skin | 1 | Skin rash |
Muscles | 1 | Myalgia |
Age of onset: newborn period.
Dou B (2024). [PMID: 38774872](https://pubmed.ncbi.nlm.nih.gov/38774872/). *Frontiers in immunology*. [Review / Meta-Analysis]
Caballero-Oteyza A (2024). [PMID: 38914362](https://pubmed.ncbi.nlm.nih.gov/38914362/). *Clinical immunology (Orlando, Fla.)*. [Review / Meta-Analysis]
Staels F (2024). [PMID: 38827742](https://pubmed.ncbi.nlm.nih.gov/38827742/). *Frontiers in immunology*. [Basic Science / Preclinical]